BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 31230978)

  • 1. The novel synonymous variant in LIPA gene affects splicing and causes lysosomal acid lipase deficiency.
    Bychkov IO; Kamenets EA; Filatova AY; Skoblov MY; Mikhaylova SV; Strokova TV; Gundobina OS; Zakharova EY
    Mol Genet Metab; 2019 Jul; 127(3):212-215. PubMed ID: 31230978
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lysosomal lipase deficiency: molecular characterization of eleven patients with Wolman or cholesteryl ester storage disease.
    Fasano T; Pisciotta L; Bocchi L; Guardamagna O; Assandro P; Rabacchi C; Zanoni P; Filocamo M; Bertolini S; Calandra S
    Mol Genet Metab; 2012 Mar; 105(3):450-6. PubMed ID: 22227072
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification and metabolic profiling of patients with lysosomal acid lipase deficiency.
    Pullinger CR; Stock EO; Movsesyan I; Malloy MJ; Frost PH; Tripuraneni R; Quinn AG; Ishida BY; Schaefer EJ; Asztalos BF; Kane JP
    J Clin Lipidol; 2015; 9(5):716-26.e1. PubMed ID: 26350820
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular and clinical characterization of a series of patients with childhood-onset lysosomal acid lipase deficiency. Retrospective investigations, follow-up and detection of two novel LIPA pathogenic variants.
    Pisciotta L; Tozzi G; Travaglini L; Taurisano R; Lucchi T; Indolfi G; Papadia F; Di Rocco M; D'Antiga L; Crock P; Vora K; Nightingale S; Michelakakis H; Garoufi A; Lykopoulou L; Bertolini S; Calandra S
    Atherosclerosis; 2017 Oct; 265():124-132. PubMed ID: 28881270
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic and biochemical evidence that CESD and Wolman disease are distinguished by residual lysosomal acid lipase activity.
    Aslanidis C; Ries S; Fehringer P; Büchler C; Klima H; Schmitz G
    Genomics; 1996 Apr; 33(1):85-93. PubMed ID: 8617513
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A new mutation in the gene for lysosomal acid lipase leads to Wolman disease in an African kindred.
    Ries S; Aslanidis C; Fehringer P; Carel JC; Gendrel D; Schmitz G
    J Lipid Res; 1996 Aug; 37(8):1761-5. PubMed ID: 8864960
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intragenic deletion as a novel type of mutation in Wolman disease.
    Lee TM; Welsh M; Benhamed S; Chung WK
    Mol Genet Metab; 2011 Dec; 104(4):703-5. PubMed ID: 21963785
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression and functional characterization of human lysosomal acid lipase gene (LIPA) mutation responsible for cholesteryl ester storage disease (CESD) phenotype.
    Rajamohan F; Reyes AR; Ruangsiriluk W; Hoth LR; Han S; Caspers N; Tu M; Ward J; Kurumbail RG
    Protein Expr Purif; 2015 Jun; 110():22-9. PubMed ID: 25620107
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lysosomal acid lipase mutations that determine phenotype in Wolman and cholesterol ester storage disease.
    Anderson RA; Bryson GM; Parks JS
    Mol Genet Metab; 1999 Nov; 68(3):333-45. PubMed ID: 10562460
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Childhood/adult-onset lysosomal acid lipase deficiency: A serious metabolic and vascular phenotype beyond liver disease-four new pediatric cases.
    Poinsot P; Collardeau Frachon S; Restier L; Sérusclat A; Di Filippo M; Charrière S; Moulin P; Lachaux A; Peretti N
    J Clin Lipidol; 2017; 11(1):167-177.e3. PubMed ID: 28391883
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular defects underlying Wolman disease appear to be more heterogeneous than those resulting in cholesteryl ester storage disease.
    Lohse P; Maas S; Sewell AC; van Diggelen OP ; Seidel D
    J Lipid Res; 1999 Feb; 40(2):221-8. PubMed ID: 9925650
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The global prevalence and genetic spectrum of lysosomal acid lipase deficiency: A rare condition that mimics NAFLD.
    Carter A; Brackley SM; Gao J; Mann JP
    J Hepatol; 2019 Jan; 70(1):142-150. PubMed ID: 30315827
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New lysosomal acid lipase gene mutants explain the phenotype of Wolman disease and cholesteryl ester storage disease.
    Pagani F; Pariyarath R; Garcia R; Stuani C; Burlina AB; Ruotolo G; Rabusin M; Baralle FE
    J Lipid Res; 1998 Jul; 39(7):1382-8. PubMed ID: 9684740
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel LIPA mutations in Mexican siblings with lysosomal acid lipase deficiency.
    Santillán-Hernández Y; Almanza-Miranda E; Xin WW; Goss K; Vera-Loaiza A; Gorráez-de la Mora MT; Piña-Aguilar RE
    World J Gastroenterol; 2015 Jan; 21(3):1001-8. PubMed ID: 25624737
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel missense LIPA gene mutation, N98S, in a patient with cholesteryl ester storage disease.
    Hooper AJ; Tran HA; Formby MR; Burnett JR
    Clin Chim Acta; 2008 Dec; 398(1-2):152-4. PubMed ID: 18775687
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Wolman disease with novel mutation of LIPA gene in a Chinese infant].
    Huang YL; Sheng HY; Zhao XY; Yu JK; Li L; Liu HS; Gu CM; He DM; Liu L
    Zhonghua Er Ke Za Zhi; 2012 Aug; 50(8):601-5. PubMed ID: 23158738
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Large-scale screening of lipase acid deficiency in at risk population.
    Tebani A; Sudrié-Arnaud B; Boudabous H; Brassier A; Anty R; Snanoudj S; Abergel A; Abi Warde MT; Bardou-Jacquet E; Belbouab R; Blanchet E; Borderon C; Bronowicki JP; Cariou B; Carette C; Dabbas M; Dranguet H; de Ledinghen V; Ferrières J; Guillaume M; Krempf M; Lacaille F; Larrey D; Leroy V; Musikas M; Nguyen-Khac E; Ouzan D; Perarnau JM; Pilon C; Ratzlu V; Thebaut A; Thevenot T; Tragin I; Triolo V; Vergès B; Vergnaud S; Bekri S
    Clin Chim Acta; 2021 Aug; 519():64-69. PubMed ID: 33857477
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Large-scale functional LIPA variant characterization to improve birth prevalence estimates of lysosomal acid lipase deficiency.
    Del Angel G; Hutchinson AT; Jain NK; Forbes CD; Reynders J
    Hum Mutat; 2019 Nov; 40(11):2007-2020. PubMed ID: 31180157
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Form of Metabolic-Associated Fatty Liver Disease Associated with a Novel LIPA Variant.
    Anushiravani A; Jafari Khamirani H; Mohamadkhani A; Mani A; Dianatpour M; Malekzadeh R
    Arch Iran Med; 2023 Feb; 26(2):86-91. PubMed ID: 37543928
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of rare diseases by screening a population selected on the basis of routine pathology results-the PATHFINDER project: lysosomal acid lipase/cholesteryl ester storage disease substudy.
    Reynolds TM; Mewies C; Hamilton J; Wierzbicki AS;
    J Clin Pathol; 2018 Jul; 71(7):608-613. PubMed ID: 29358478
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.